EUCTR2008-005082-64-IT进行中（未招募）不适用
EVALUATION OF THE EFFICACY AND SAFETY OF A NEW STEROID-ANTIBIOTIC OPHTHALMIC GEL AS ANTI-INFLAMMATORY AND ANTIMICROBIAL TOPICAL TREATMENT FOLLOWING MICROINCISIONAL VITREO-RETINAL SURGERY. - ND
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- SIFI
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Subjects showing epiretinal macular membranes and having to undergo sutureless 23-25 gauge vitreoretinal surgery; 2.Able and willing to give informed consent; 3.Age between 30-70 years; 4.Any race and sex; 5.Willing and able to attend required study visits.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.Recurrent anterior or posterior segment inflammation of unknown aetiology or history of inflammation and/or ocular trauma in the affected eye during the last 12 months; 2.Concomitant systemic and ocular pathologies (diabetes, ocular infections, glaucoma, ocular hypertension, severe dry-eye); 3.Patients having to undergo a combined vitreo-retinal and cataract extraction surgery; 4.Patients who underwent preceding vitreo-retinal surgeries adopting a buckling procedure; 5.Patients who underwent preceding laser or cryotherapy retinopexi; 6.Cataract surgery in the affected eye within 3 months before the beginning of the study; 7.Ocular surgery in the affected eye, other than cataract extraction, within 12 months before the beginning of the study; 8.Intraocular pressure >22 mmHg; 9.Intake of any pharmaceutical form of antibiotics, antihistamines, decongestants, steroids or non-steroidal anti-inflammatory agents within 14 days prior to study entry 10.Use of ocular medication other than artificial tears; 11.Known or suspected allergy to ocular preservatives, aminoglycosides and steroids; 12.Subjects currently participating in another clinical study or who have participated in a clinical study in the preceding 30 days; 13.Pregnant or nursing women or inadequate birth control methods (applicable to female of childbearing potential only); 14.Monophthalmic. Moreover, the following intra-operative exclusion criteria will be considered: 1.Intra-vitreal administration of triamcinolone acetonide; 2.Use of tamponating gas; 3.Need for suture.
研究者
相似试验
已完成
不适用
A STUDY TO DETERMINE THE SAFETY AND EFFICACY OF STI571 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA THAT ARE HEMATOLOGICALLY OR CYGOGENICALLY RESISTANT OR REFRACTORY OR INTOLERANT TO THE ALPHA INTERFERO-C921 Chronic myeloid leukaemia [CML], BCR/ABL-positiveChronic myeloid leukaemia [CML], BCR/ABL-positiveC921PER-004-01OVARTIS BIOSCIENSES PERU S.A.,
已完成
不适用
A STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STI571 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN ACCELERATED PHASE-C921 Chronic myeloid leukaemia [CML], BCR/ABL-positiveChronic myeloid leukaemia [CML], BCR/ABL-positiveC921PER-073-00OVARTIS BIOSCIENSES PERU S.A.,
尚未招募
Unknown
To know if the mouth wash prepared from certain herbal products is effective and safe to treat the gingivitisCTRI/2024/01/061413DR ZADC AMU ALIGARH
已完成
不适用
A pilot study of a novel Sternal Protection Device to evaluate its safety in 12 patients requiring a cardiothoracic surgeryACTRN12616000091404Protego Medical Pty Ltd12
已完成
不适用
Evaluation of efficucy and safety of newly developed capsule endoscope and software.Small bowel diseaseJPRN-UMIN000010976Center for Diagnostic and Therapeutic Endoscopy, School of Medicine, Keio University40